铁死亡在放射性肺炎中的作用机制及中西医干预研究进展
Ferroptosis in Radiation Pneumonitis: Mechanisms and Advances in Interventions Combining Traditional Chinese and Western Medicine
DOI: 10.12677/tcm.2026.157354, PDF,   
作者: 曾培艳*, 冯俊尧, 韩 东:广西中医药大学,广西 南宁;许光兰#:广西中医药大学第一附属医院,广西 南宁
关键词: 铁死亡放射性肺炎中西医干预Ferroptosis Radiation Pneumonitis Integrated Traditional Chinese and Western Medicine Intervention
摘要: 放射性肺炎(Radiation Pneumonitis, RP)是胸部肿瘤放疗后常见的严重并发症,其发病机制复杂,涉及氧化应激、炎症反应及多种细胞死亡形式。近年来,铁死亡作为一种铁依赖性的非凋亡细胞死亡形式,在放射性肺炎的发生发展中受到广泛关注。现有研究表明,放疗诱导的活性氧爆发可导致铁代谢紊乱、脂质过氧化物堆积及谷胱甘肽过氧化物酶4 (GPX4)失活,进而触发肺部细胞铁死亡,促进炎症级联反应和肺纤维化进程。然而,现有研究多集中于单一机制或药物干预,缺乏对铁死亡调控网络的系统整合。本综述系统论述铁死亡在放射性肺炎中的分子机制并总结中西医干预的最新进展,旨在为临床防治提供新思路。
Abstract: Radiation pneumonitis is a common and serious complication following radiotherapy for thoracic tumors. Its pathogenesis is complex, involving oxidative stress, inflammatory responses and various forms of cell death. In recent years, ferroptosis—an iron-dependent form of non-apoptotic cell death—has attracted widespread attention in relation to the development of radiation pneumonitis. Existing research indicates that radiotherapy-induced bursts of reactive oxygen species can lead to iron metabolism disorders, the accumulation of lipid peroxides and the inactivation of glutathione peroxidase 4, thereby triggering ferroptosis in pulmonary cells and promoting inflammatory cascades and the progression of pulmonary fibrosis. However, existing studies have largely focused on single mechanisms or drug interventions, lacking a systematic integration of the ferroptosis regulatory network. This review systematically discusses the molecular mechanisms of ferroptosis in radiation pneumonitis and summarizes the latest advances in both Western and traditional Chinese medical interventions, aiming to provide new insights and targets for clinical prevention and treatment.
文章引用:曾培艳, 冯俊尧, 韩东, 许光兰. 铁死亡在放射性肺炎中的作用机制及中西医干预研究进展[J]. 中医学, 2026, 15(7): 23-30. https://doi.org/10.12677/tcm.2026.157354

参考文献

[1] Xia, C., Shi, W., Zhang, Y., Ding, L., Gao, L., Wang, Q., et al. (2020) Prevention and Treatment of Radiation-Induced Lung Injury. Future Medicinal Chemistry, 12, 2161-2173. [Google Scholar] [CrossRef] [PubMed]
[2] Liu, X., Shao, C. and Fu, J. (2021) Promising Biomarkers of Radiation-Induced Lung Injury: A Review. Biomedicines, 9, Article No. 1181. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, Y., Zhang, J. and Shao, C. (2024) Cytological Changes in Radiation-Induced Lung Injury. Life Sciences, 358, Article ID: 123188. [Google Scholar] [CrossRef] [PubMed]
[4] Arroyo-Hernández, M., Maldonado, F., Lozano-Ruiz, F., Muñoz-Montaño, W., Nuñez-Baez, M. and Arrieta, O. (2021) Radiation-Induced Lung Injury: Current Evidence. BMC Pulmonary Medicine, 21, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[5] Yan, Y., Fu, J., Kowalchuk, R.O., Wright, C.M., Zhang, R., Li, X., et al. (2022) Exploration of Radiation-Induced Lung Injury, from Mechanism to Treatment: A Narrative Review. Translational Lung Cancer Research, 11, 307-322. [Google Scholar] [CrossRef] [PubMed]
[6] Chang, S., Lv, J., Wang, X., Su, J., Bian, C., Zheng, Z., et al. (2024) Pathogenic Mechanisms and Latest Therapeutic Approaches for Radiation-Induced Lung Injury: A Narrative Review. Critical Reviews in Oncology/Hematology, 202, Article ID: 104461. [Google Scholar] [CrossRef] [PubMed]
[7] Guo, H., Yu, R., Zhang, H. and Wang, W. (2024) Cytokine, Chemokine Alterations and Immune Cell Infiltration in Radiation-Induced Lung Injury: Implications for Prevention and Management. International Immunopharmacology, 126, Article ID: 111263. [Google Scholar] [CrossRef] [PubMed]
[8] Li, X., Chen, J., Yuan, S., Zhuang, X. and Qiao, T. (2022) Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation‐Induced Lung Injury. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 8973509. [Google Scholar] [CrossRef] [PubMed]
[9] Yan, H., Zou, T., Tuo, Q., Xu, S., Li, H., Belaidi, A.A., et al. (2021) Ferroptosis: Mechanisms and Links with Diseases. Signal Transduction and Targeted Therapy, 6, Article No. 49. [Google Scholar] [CrossRef] [PubMed]
[10] Li, S. and Huang, Y. (2022) Ferroptosis: An Iron-Dependent Cell Death Form Linking Metabolism, Diseases, Immune Cell and Targeted Therapy. Clinical and Translational Oncology, 24, 1-12. [Google Scholar] [CrossRef] [PubMed]
[11] Javadov, S. (2022) Mitochondria and Ferroptosis. Current Opinion in Physiology, 25, Article ID: 100483. [Google Scholar] [CrossRef] [PubMed]
[12] Karimian, F., Khademi, M., Bahrami, A.N., Nabigol, M., Mikanik, F., Bakhtiyaridovvombaygi, M., et al. (2025) Iron-dependent Cell Death: Unlocking Ferroptosis as a Key to Multiple Myeloma Therapy. Clinical Immunology, 280, Article ID: 110570. [Google Scholar] [CrossRef] [PubMed]
[13] 谭鑫, 张沛, 杜乐辉, 等. 间充质干细胞通过抑制铁死亡减轻小鼠放射性肺损伤的作用机制研究[J]. 中国医学装备, 2024, 21(5): 176-183.
[14] Xiang, Y., Song, X. and Long, D. (2024) Ferroptosis Regulation through Nrf2 and Implications for Neurodegenerative Diseases. Archives of Toxicology, 98, 579-615. [Google Scholar] [CrossRef] [PubMed]
[15] Yuan, W., Xia, H., Xu, Y., Xu, C., Chen, N., Shao, C., et al. (2022) The Role of Ferroptosis in Endothelial Cell Dysfunction. Cell Cycle, 21, 1897-1914. [Google Scholar] [CrossRef] [PubMed]
[16] 张钰浛, 杨丽娜. 铁死亡与继发性肾脏病[J]. 中南大学学报(医学版), 2024, 49(3): 377-384.
[17] 朱琳, 王瑞芳, 郑莹莹, 等. 脂质过氧化与铁死亡研究进展[J]. 新乡医学院学报, 2026, 43(3): 242-247.
[18] Dörschmann, P., Apitz, S., Hellige, I., Neupane, S., Alban, S., Kopplin, G., et al. (2021) Evaluation of the Effects of Fucoidans from Fucus Species and Laminaria hyperborea against Oxidative Stress and Iron-Dependent Cell Death. Marine Drugs, 19, Article No. 557. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, Y., Yu, G. and Chen, X. (2024) Mechanism of Ferroptosis Resistance in Cancer Cells. Cancer Drug Resistance, 7, Article No. 47. [Google Scholar] [CrossRef] [PubMed]
[20] Tan, L., Liu, J., Ma, C., Huang, S., He, F., Long, Y., et al. (2025) Iron-Dependent Cell Death: Exploring Ferroptosis as a Unique Target in Triple-Negative Breast Cancer Management. Cancer Management and Research, 17, 625-637. [Google Scholar] [CrossRef] [PubMed]
[21] Hu, H., Chen, Y., Jing, L., Zhai, C. and Shen, L. (2021) The Link between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment. Frontiers in Cardiovascular Medicine, 8, Article ID: 710963. [Google Scholar] [CrossRef] [PubMed]
[22] Qian, X., Wang, Y., Kuang, P., Li, B., Jiang, K., Wang, A., et al. (2026) Ionizing Radiation Promotes Lung Injury by Inducing Ferroptosis-Driven Senescence in Epithelial Cells via NCOA4-Mediated Ferritinophagy. Redox Biology, 91, Article ID: 104091. [Google Scholar] [CrossRef
[23] Ning, X., Zhao, W., Wu, Q., Wang, C. and Liang, S. (2024) Therapeutic Potential of Dihydroartemisinin in Mitigating Radiation‐Induced Lung Injury: Inhibition of Ferroptosis through Nrf2/HO‐1 Pathways in Mice. Immunity, Inflammation and Disease, 12, e1175. [Google Scholar] [CrossRef] [PubMed]
[24] 林樱, 赵俊凯, 徐静静. 黄芩素通过调控SIRT1/FOXO1通路抑制铁死亡减轻脓毒症小鼠急性肺损伤[J/OL]. 解剖科学进展, 1-8.
https://link.cnki.net/urlid/21.1347.Q.20260421.1013.016, 2026-06-26.
[25] 杨文哲, 王锦浩, 赵子琛, 等. 姜黄素影响铁死亡途径缓解LPS诱导牛乳腺上皮细胞炎性反应的分析[J]. 畜牧兽医学报, 2025, 56(9): 4730-4740.
[26] 王稼骏, 周静. 穿心莲内酯通过HIF-1α/SLC7A11/GPX4轴诱导导致肝癌细胞铁死亡机制研究[J/OL]. 海南医科大学学报, 1-14. 2026-06-26.[CrossRef
[27] 吕景山. 施今墨对药(彩色图文版) [M]. 北京: 人民卫生出版社, 2026.
[28] 王艳, 刘茵, 贺晓丽. 丹参葛根提取物抑制Erastin诱导的HT22细胞铁死亡[J]. 中药药理与临床, 2025, 41(2): 47-53.
[29] 李永顺, 谢嘉嘉, 李航, 等. 基于生物信息学及铁死亡分析特发性肺纤维化的差异基因及潜在的治疗中药预测[J]. 药物评价研究, 2023, 46(3): 501-509.
[30] 赵信燕, 岳晓霞, 张惠丽, 等. 丹参酮调节cGAS-STING信号通路对急性肺栓塞大鼠炎性损伤的影响[J]. 中国老年学杂志, 2025, 45(17): 4321-4326.
[31] Hatcher, H.C., Singh, R.N., Torti, F.M. and Torti, S.V. (2009) Synthetic and Natural Iron Chelators: Therapeutic Potential and Clinical Use. Future Medicinal Chemistry, 1, 1643-1670. [Google Scholar] [CrossRef] [PubMed]
[32] 赵苗苗, 杨轶童, 陈露萍, 等. 川芎嗪通过激活SIRT1信号抑制铁死亡减轻脂多糖致内皮细胞炎症损伤[J]. 心脏杂志, 2025, 37(4): 380-386.
[33] Chen, Y. and Wu, M. (2023) Exploration of Molecular Mechanism Underlying Protective Effect of Astragaloside IV against Radiation-Induced Lung Injury by Suppressing Ferroptosis. Archives of Biochemistry and Biophysics, 745, Article ID: 109717. [Google Scholar] [CrossRef] [PubMed]
[34] 孙亚利, 王彬蒙, 丁新月, 等. 基于脂质过氧化途径探讨黄芪甲苷对高糖诱导人足细胞铁死亡的保护作用[J]. 中医药导报, 2025, 31(6): 26-30.
[35] 文丹, 付成, 丁菲. 麦冬多糖的抗氧化、降血糖活性研究[J]. 江汉大学学报(自然科学版), 2023, 51(3): 55-67.
[36] 马波, 张梦卓, 何麒, 等. 电针“气海” “中极” “关元”穴抑制压力性尿失禁大鼠尿道括约肌铁死亡的机制研究[J]. 中国病理生理杂志, 2025, 41(11): 2229-2236.
[37] 张正则, 刘浩, 何悦雯, 等. 电针调控哮喘小鼠肺组织Keap1/Nrf2通路缓解铁死亡的机制研究[J]. 针刺研究, 2025, 50(9): 983-994.
[38] 彭传玉, 王天城, 蔡荣林, 等. 艾灸调控铁死亡-脂质代谢通路改善类风湿性关节炎大鼠滑膜炎性损伤的机制研究[J]. 针刺研究, 2024, 49(12): 1296-1302.